The immune system’s pro-inflammatory environment in IBD, characterized by cytokine dysregulation (e.g., TNF-α, IL-6, IL-1β), may contribute to systemic inflammation, further exacerbating insulin resistance in older individuals. The gene discussed is IL1B; the disease is Insulin resistance.